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Background. Although STAT5 promotes survival of hematopoietic progenitors, STAT5
2/2 mice develop mild neutrophilia.
Methodology/Principal findings. Here, we show that in STAT5
2/2 mice, liver endothelial cells (LECs) autonomously secrete
high amounts of G-CSF, allowing myeloid progenitors to overcompensate for their intrinsic survival defect. However, when
injected with pro-inflammatory cytokines, mutant mice cannot further increase neutrophil production, display a severe
deficiency in peripheral neutrophil survival, and are therefore unable to maintain neutrophil homeostasis. In wild-type mice,
inflammatory stimulation induces rapid STAT5 degradation in LECs, G-CSF production by LECs and other cell types, and then
sustained mobilization and expansion of long-lived neutrophils. Conclusion. We conclude that STAT5 is an ambivalent factor.
In cells of the granulocytic lineage, it exerts an antiapoptotic function that is required for maintenance of neutrophil
homeostasis, especially during the inflammatory response. In LECs, STAT5 negatively regulates granulopoiesis by directly or
indirectly repressing G-CSF expression. Removal of this STAT5-imposed brake contributes to induction of emergency
granulopoiesis.
Citation: Fie ´vez L, Desmet C, Henry E, Pajak B, Hegenbarth S, et al (2007) STAT5 Is an Ambivalent Regulator of Neutrophil Homeostasis. PLoS ONE 2(8):
e727. doi:10.1371/journal.pone.0000727
INTRODUCTION
Neutrophils represent 60% of the total circulating leukocytes in
humans, and form the first line of host defence against invading
microorganisms. Under physiological conditions, neutrophils un-
dergo constitutive apoptosis within 6–18 h of entry into the
bloodstream [1]. Therefore, 10
11 neutrophils need to be produced
daily in thebonemarrow to maintain homeostasis [2].In response to
pathogen infection, neutrophils quickly migrate into peripheral
tissues where they amplify the inflammatory response through the
release of cytokines such as TNF-a [3]. While participating in the
inflammatory process, neutrophils kill pathogens using several
microbicidal mechanisms, including phagocytosis and production
ofreactive oxygenintermediates [3,4].The inflammatoryresponseis
accompanied by an expansion of the peripheral neutrophil pool that
results from increased neutrophil survival and enhanced neutrophil
production, a process known as emergency granulopoiesis [1,5,6].
The current model of hematopoiesis proposes that early in their
differentiation, long-term hematopoietic stem cells (HSCs) lose their
capacity for self-renewal, differentiating first into short-term HSCs
and subsequently to multipotent progenitors (MPPs) [7]. MPPs
generate common myeloid progenitors (CMPs) that are able to
differentiate into the erythromyeloid lineages, and common lymphoid
progenitors that produce B, T, and natural killer cells. CMPs may
form two more restricted cell types, the granulocyte-macrophage
progenitors (GMPs) and the megakaryocyte-erythrocyte progenitors.
Neutrophils develop from GMPs through the myeloblast, the
promyelocyte, the myelocyte, and the metamyelocyte stages.
G-CSFisrecognizedastheprimaryextracellularregulatorofboth
basal and emergency granulopoiesis [8–11]. The importance of
G-CSF to in vivo granulopoiesis was demonstrated in mice carrying
a homozygous null mutation for G-CSF or G-CSF receptor. These
mice had 12–30% of normal circulating neutrophils and a corre-
sponding decrease in granulocytic precursors in their bone marrow
[10,11]. Multiple actions of G-CSF have been described that may
contribute to the neutrophilic response. First, G-CSF stimulates
proliferation and terminal differentiation of granulocytic precursors
[12]. Second, it reduces the average transit time through the
granulocytic compartment [12,13]. Third, it regulates neutrophil
trafficking from the bone marrow to the blood [14]. Fourth, it
stimulates a broad range of mature neutrophil functions [15].
Finally, G-CSF prolongs neutrophil survival [16].
Most biological functions of G-CSF are mediated through
STAT1, STAT3, and STAT5 [17–19]. However, a requirement
for STAT1 in G-CSF-driven myeloid cell proliferation is unlikely,
given the normal production of granulocytes in STAT1-deficient
mice [20]. STAT3 and SOCS3 (viz. a suppressor of cytokine
signalling, the expression of which is induced by STAT3) are
negative regulators of granulopoiesis. Indeed, mice lacking any of
these proteins in their hematopoietic compartment develop
neutrophilia, and their bone marrow cells are hyperresponsive to
G-CSF stimulation [21,22]. Several lines of evidence suggest that
STAT5 is implicated in neutrophil development. First, loss of
STAT5 function in primary bone marrow cells leads to a reduction
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PLoS ONE | www.plosone.org 1 August 2007 | Issue 8 | e727in CFU-G colony formation in vitro [23,24]. Second, STAT5
favors the survival of myeloid progenitors by inducing the
expression of Bcl-xL, an antiapoptotic protein of the Bcl-2 family
[25]. Third, bone marrow cells from mice lacking both STAT5
isoforms, STAT5a and STAT5b, are unable to repopulate the
neutrophilic granulocyte lineage of lethally irradiated wild-type
hosts [26,27]. Disconcertingly, however, STAT5ab
2/2 mice
spontaneously develop mild neutrophilia [23,27].
The purpose of the current study was to definitively clarify the
role of STAT5 in neutrophil homeostasis. To determine the net
effects of STAT5 proteins on neutrophil homeostasis, we have
chosen to use the STAT5a/b double-knockout mice (23; hereafter
referred to as STAT5
2/2 mice).
RESULTS
Increased Numbers of Functional Neutrophils in the
Periphery of STAT5
2/2 Mice
We first examined the peripheral blood counts of wild-type and
STAT5
2/2 mice. The total leukocyte counts in STAT5
2/2
animals were about 2-fold lower than in wild-type controls. This
effect was largely due to lymphopenia. However, STAT5
2/2
animals displayed mild neutrophilia (3.261.0610
3 neutrophils/ml
in STAT5
2/2 mice versus 1.660.4610
3 neutrophils/ml in wild-
type controls, n=22, P,.001) as well as mild monocytosis,
a finding that is in accordance with previous reports [23,27].
Neutrophil migration in STAT5
2/2 mice was examined in
a thioglycollate (TGA)-induced peritonitis model. At 4 h after
TGA injection, the absolute number of neutrophils in the
peritoneal cavity of STAT5
2/2 animals was about 2-fold higher
than in wild-type littermates. Moreover, neutrophils isolated from
the peritoneal space of TGA-treated STAT5
2/2 mice were
morphologically mature and stained normally for Gr-1 and
CD11b, two late-stage markers of neutrophil differentiation (data
not shown). Finally, STAT5
2/2 peritoneal neutrophils displayed
a respiratory oxidative burst, and were able to produce high
quantities of TNF-a and to phagocytose and kill bacteria
(Figures 1A–D).
Taken together, these results confirm that STAT5
2/2
mice spontaneously develop mild neutrophilia and show that
STAT5
2/2 neutrophils are functional.
Neutrophilia in STAT5
2/2 mice is due to increased
granulopoiesis
We hypothesized that neutrophilia in STAT5
2/2 mice could be
due to enhanced survival of peripheral neutrophils, to increased
granulopoiesis, or to a combination of these two mechanisms.
Figure 1. Peripheral STAT5
2/2 neutrophils are functional. (A) Peritoneal neutrophils from TGA-treated wild-type (WT) or STAT5
2/2 mice were
analyzed for oxidation of dihydrorhodamine to fluorescent rhodamine by FACS with or without treatment with PMA (1 mg/ml). (B) STAT5
2/2
neutrophils are able to produce TNF-a.1 610
6 peritoneal neutrophils from control or mutant mice were stimulated for 6 h with PMA (1 mg/ml), and
TNF-a concentration in cell supernatants was then measured by ELISA. (C) STAT5
2/2 neutrophils are phagocytic. CFSE-labeled Staphylococcus aureus
were incubated with peritoneal neutrophils at 37uC for 30 min (T0), and gentamycin was added for an additional 30 min (T30). Cells washed free of
extracellular bacteria at T0 or T30 min were analyzed by FACS for engulfed bacteria. (D) STAT5
2/2 neutrophils are bactericidal. Engulfed bacteria were
released by lysing peritoneal neutrophils in 1 ml water. One hundred microliters of a 1:1,000 dilution of the bacterial suspension was plated and
colonies were counted after a 24-h incubation at 37uC.
doi:10.1371/journal.pone.0000727.g001
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2/2 and control
mice displayed low and similar levels of apoptosis (Figure 2A).
After 24 h of culture, apoptosis levels were substantially increased
and were significantly greater in neutrophils from STAT5
2/2
mice than in those from wild-type controls (Figure 2A), invalidat-
ing the hypothesis that neutrophilia in STAT5
2/2 mice is the
consequence of enhanced survival of peripheral neutrophils. Blood
neutrophils were also cultured for 24 h in the presence of G-CSF
or GM-CSF, two antiapoptotic cytokines [16]. Both G-CSF and
GM-CSF were able to partially inhibit apoptosis of wild-type
neutrophils, whereas STAT5
2/2 neutrophils did not respond to
these cytokines (Figure 2A).
We next examined whether neutrophil production was in-
creased in STAT5
2/2 mice. Although STAT5
2/2 mice showed
a ,20% reduction in the total number of bone marrow cells
(Figure 2B), the absolute number of mature neutrophils
(CD11b
+Gr-1
hi) in the bone marrow of these mice was
significantly increased relative to wild-type littermates
(Figure 2C). The CMP, the GMP, the myeloblast, the promye-
locyte, the myelocyte, and the metamyelocyte populations were
also substantially increased, whereas the HSC population was
unchanged, in STAT5
2/2 animals relative to wild-type controls
(Figures 2D–2F; data not shown). Finally, we found that the
apoptosis rate of FACS-purified HSCs, CMPs, GMPs, and
marrow neutrophils was higher in STAT5
2/2 mice than in
controls (Figure 2G). Altogether, these results indicate that
neutrophilia in STAT5
2/2 mice is due to increased granulopoiesis
rather than to enhanced neutrophil survival.
Increased granulopoiesis in STAT5
2/2 mice is
associated with elevated G-CSF production
To investigate whether increased neutrophil production in
STAT5
2/2 mice could be the consequence of an aberrant
production of cytokines involved in granulopoiesis, we measured
the concentrations of G-CSF, GM-CSF, IL-3, and stem cell factor
(SCF) in the serum of wild-type and mutant mice. Both wild-type
and STAT5
2/2 mice had undetectable serum GM-CSF and IL-3.
Serum levels of SCF were similar in both mice, whereas G-CSF
levels were ,25-fold higher in STAT5
2/2 mice than in controls
(Figure 3A). Such a phenomenon could explain why STAT5
2/2
mice display enhanced granulopoiesis and develop neutrophilia.
Figure 2. Increased granulopoiesis in STAT5
2/2 mice. (A) Apoptosis of peripheral neutrophils. MACS-purified blood peripheral neutrophils from
wild-type (WT) and STAT5
2/2 mice were cultured for 24 hr in the absence or presence of 0.5 or 25 ng/ml G-CSF or 25 ng/ml GM-CSF. Freshly purified
(T0) and 24-hr cultured (T24) neutrophils were assayed for apoptosis using dual color annexin-V-FITC/propidium iodide staining and flow cytometry
analyses. *, significantly different from T0 values with P,0.05. u, significantly different from WT values with P,0.05. (B) Bone marrow was harvested
from both hind limbs of either WT or STAT5
2/2 mice, and cell counts were determined after red blood cell lysis. (C–F) Mature marrow neutrophils
(CD11c
+Gr-1
hi cells), GMPs (Lin
2Sca-1
2IL-7Ra
2c-kit
+CD34
+FccR
+ cells), CMPs (Sca-1
2IL-7Ra
2c-kit
+CD34
+FccR
low cells), and HSCs (Lin
2Sca-1
hiIL-7Ra
2c-
kit
hi) from the bone marrow of control and mutant mice were counted by flow cytometry. Absolute values were generated by multiplying gated
percentages by total cell numbers. (G) Freshly FACS-purified marrow neutrophils, GMPs, CMPs, and HSCs were assayed for apoptosis using trypan
blue exclusion. (B–G) *, significantly different from WT values with P,0.05.
doi:10.1371/journal.pone.0000727.g002
Role of STAT5 in Neutrophil
PLoS ONE | www.plosone.org 3 August 2007 | Issue 8 | e727To test this hypothesis, bone marrow cells were isolated from wild-
type and mutant mice, and their proliferative response to G-CSF
was assayed. As illustrated in Figure 3B, the proliferative response
of STAT5
2/2 cells to G-CSF was significantly reduced relative to
that of control cells. However, STAT5
2/2 bone marrow cells
stimulated in vitro with G-CSF at a concentration equivalent to
that measured in the serum of STAT5
2/2 mice (500 pg/ml)
displayed a 1.7-fold and a 2.5-fold increase in proliferation,
respectively, compared with wild-type cells and mutant cells
stimulated with G-CSF at a physiological concentration
(20 pg/ml). Thus, although the proliferative response of mutant
bone marrow cells to G-CSF is reduced, the increased neutrophil
production observed in STAT5
2/2 mice is recapitulated ex vivo
by stimulating the cells with appropriate G-CSF concentrations. In
this experiment, we have hypothesized that the concentration of
G-CSF in the bone marrow was equivalent to that in the serum.
Taken together, these data show that G-CSF production is
increased in STAT5
2/2 mice, allowing mutant progenitors to
overcompensate for their hyporesponsiveness to this cytokine.
STAT5
2/2 liver endothelial cells autonomously
produce high quantities of G-CSF
To identify the source of G-CSF in vivo, we first analyzed various
organs and tissues from wild-type and STAT5
2/2 mice for their
relative expression of G-CSF mRNA. In both control and mutant
mice, the G-CSF transcript was predominantly detected in the
liver (Figure 4A). However, G-CSF mRNA levels were ,15-fold
higher in STAT5
2/2 than in normal liver. G-CSF mRNA was
also detected at low levels in the heart of mutant mice. No G-CSF
mRNA was found in intestines, lungs, kidneys, skin, spleen, bone
marrow, lymph nodes, and white blood cells from control and
STAT5
2/2 mice. Immunohistochemistry revealed that G-CSF
protein expression was restricted to endothelial cells lining the
central veins and sinusoidal endothelial cells (both these cell types
are hereafter referred to as liver endothelial cells, LECs) in the liver
of STAT5
2/2 mice (Figure 4B, lower panel). In wild-type mice,
liver cells did not stain for G-CSF (Figure 4B, upper panel), except
in some fields where G-CSF-positive LECs could be detected (data
not shown). Of note, some endothelial cells staining for G-CSF
were found in auricles and aorta of STAT5
2/2 mice (data not
shown). No signal was found in any of the other organs (data not
shown).
We next sought to determine whether LECs from STAT5
2/2
mice were able to autonomously secrete G-CSF. Control and
STAT5
2/2 liver sinusoidal endothelial cells (LSECs) were isolated
and cultured for 3 days. The medium was then replaced by fresh
medium and the cells were cultured for an additional 6 h, after
which supernatants were harvested and analyzed for G-CSF
concentration by ELISA. G-CSF was barely detectable in the
supernatants of wild-type LSECs (Figure 4C). Conversely,
significant levels of G-CSF were found in the supernatants of
mutant cells, indicating that STAT5
2/2 LSECs are capable of
releasing high amounts of G-CSF without external stimulation.
STAT5b is rapidly degraded in wild-type LECs
following inflammatory stimulation
To assess whether our observations in STAT5
2/2 mice are of
physiological relevance, we investigated the expression and
activation of STAT5 in wild-type LECs under steady-state
conditions and following inflammatory stimulation. First, confocal
microscopy was used to visualize STAT5a and STAT5b in liver
sections from wild-type mice. Under physiological conditions,
STAT5b was expressed at high levels in LECs, but was barely
detectable in other liver cells (Figure 5Aa). STAT5a was not
present in LECs (data not shown). Of note, STAT5b was
exclusively located in the cytoplasm of LECs; no staining was
ever observed in the nucleus (Figure 5Aa, arrows). Thirty minutes
after intravenous injection of wild-type mice with TNF-a and IL-
1b, STAT5b was no longer detected in LECs (Figure 5Ad),
indicating that inflammatory stimulation induces rapid degrada-
tion of cytoplasmic STAT5b in these cells. Subsequent to STAT5b
degradation, G-CSF mRNA and protein expression significantly
increased in the liver, as determined by real time quantitative RT-
PCR and immunohistochemistry (Figures 5B and C). G-CSF
Figure 3. Association between increased granulopoiesis and elevated G-CSF production in STAT5
2/2 mice. (A) Elevated G-CSF serum levels in
STAT5
2/2 mice. G-CSF and SCF concentrations in the serum of wild-type (WT) and STAT5
2/2 mice were determined by ELISA. *, significantly different
from WT values with P,0.05. (B) Proliferation of bone marrow cells from wild-type and mutant mice in response to G-CSF. 2610
5 STAT5
2/2 or control
bone marrow cells were cultured with G-CSF in various concentrations for 48 hr before cells were pulsed with
3[H]thymidine for 16 hr. Note that
mutant cells stimulated with 5610
21 ng/ml G-CSF displayed a 1.7-fold and a 2.5-fold increase in proliferation, respectively, compared with control
cells and mutant cells stimulated with 2610
22 ng/ml G-CSF. (A, B) *, significantly different from WT values with P,0.05.
doi:10.1371/journal.pone.0000727.g003
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kidney, and spleen macrophages following inflammatory stimula-
tion (data not shown).
To examine direct effects of inflammatory stimulation on
STAT5 expression, LSECs were isolated from wild-type mice and
activated ex vivo with TNF-a and IL-1b. Western blotting
revealed the presence of STAT5b, but not STAT5a, in
cytoplasmic extracts from wild-type LSECs at steady-state
(Figure 5D). 1 h after TNF-a and IL-1b stimulation, STAT5b
was no longer detectable in the cytoplasm of LSECs (Figure 5D).
As STAT5b was not present in nuclear extracts at any time point
(Figure 5D), we concluded that STAT5b was degraded rather than
translocated to the nucleus. After 3 h, STAT5b was resynthesized,
but after 6 h of activation, STAT5b was found to be degraded
again. Absence of STAT5b nuclear translocation and DNA-
binding activity was confirmed by EMSAs (Figure 5E), and the
ability of the anti-STAT5b antibody to recognize phosphorylated
STAT5b was checked by performing immunoblots with nuclear
extracts from GM-CSF-treated murine neutrophils (data not
shown), in which STAT5b is known to be rapidly phosphorylated
and translocated to the nucleus [28]. Finally, ELISAs showed that
G-CSF production by LSECs was increased at 3 and at 6 h
poststimulation (Figure 5F). STAT5b was already degraded at 1 h
poststimulation (Figure 5D). However, G-CSF production was
only detected after 3 h, when STAT5b was resynthetized
(Figures 5D and 5F). This apparent discrepancy may be explained
by the fact that there is a delay i) between STAT5b degradation
and G-CSF release (this delay corresponds to the time required for
G-CSF transcription, translation and secretion) and ii) between
STAT5b resynthesis and complete inhibition of G-CSF expression
(this delay correspond to the time needed for the elimination of
residual G-CSF transcripts). It has been reported that cytoplasmic
STAT5 may be ubiquitinated and degraded by the proteasome
[29]. To determine whether inflammatory stimulation leads to
proteasomal degradation of cytoplasmic STAT5b in liver
endothelium, LSECs were isolated and treated with the protea-
some inhibitor MG132 30 min prior to stimulation with
TNF-a and IL-1b. Cytoplasmic extracts were prepared 1, 3, and
Figure 4. STAT5
2/2 LECs produce high amounts of G-CSF. (A) Elevated G-CSF mRNA expression in the liver of STAT5
2/2 mice. Liver and heart from
wild-type (WT) and STAT5
2/2 mice were assayed for G-CSF mRNA expression by real time quantitative RT-PCR. All values are normalized to b–actin
mRNA. No G-CSF mRNA was detected in WT heart. (B) LECs are the source of G-CSF in STAT5
2/2 mice. Liver sections from WT and mutant mice were
stained to detect G-CSF (brown). Both endothelial cells lining the central vein (open arrow) and sinusoidal endothelial cells (solid arrow) stained for G-
CSF. Original magnification, 2506. (C) STAT5
2/2 LSECs autonomously produce high quantities of G-CSF. WT and STAT5
2/2LSECs were isolated,
seeded onto 6-well flat-bottom plates at a density of 5610
6 cells/well, and cultured for 3 days after which the medium was refreshed. Supernatants
were harvested 6 hr later and analyzed for G-CSF concentration by ELISA. *, significantly different from WT values with P,0.05.
doi:10.1371/journal.pone.0000727.g004
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Figure 5G shows that MG132 completely prevented the
disappearance of cytoplasmic STAT5b in stimulated LSECs,
unambiguously demonstrating that in these cells, cytoplasmic
STAT5b is degraded by the proteasome. Moreover, real-time
quantitative RT-PCR revealed that STAT5b mRNA levels were
not altered in TNF-a- and IL-1b-stimulated LSECs (Figure 5H),
indicating that transcriptional or post-transcriptional mechanisms
do not account for the decrease in cytoplasmic STAT5b protein
levels observed in LSECs upon inflammatory stimulation.
Altogether, these data demonstrate that STAT5b is rapidly
degraded by the proteasome in LECs following inflammatory
stimulation, and that STAT5b degradation precedes enhancement
of G-CSF production by these cells.
Neutrophil homeostasis cannot be maintained in
STAT5
2/2 mice upon inflammatory stimulation
We next compared the inflammatory response in STAT5
2/2 mice
with that in wild-type mice. Inflammation was provoked by
intravenous injection of IL-1b and TNF-a. Serum G-CSF
concentrations increased substantially in both wild-type and
mutant mice during the first 6 h after injection, and then gradually
decreased to reach basal values by 48 h (Figure 6A). In wild-type
mice, blood neutrophil numbers were slightly, but significantly,
increased at 24 and 48 h after cytokine administration (Figure 6B).
In STAT5
2/2 mice, although a ,2-fold rise in blood neutrophil
counts was observed at 6 h, neutrophil numbers dropped to only
31 and 25% of the initial values at 24 and 48 h postinjection,
respectively (Figure 6B).
During the inflammatory response, both neutrophil production
and survival are enhanced [1,5,6], allowing continuous replace-
ment of extravasated neutrophils. We thus investigated whether
these homeostatic mechanisms were deficient in STAT5
2/2 mice
during cytokine-induced inflammation. The absolute number of
bone marrow neutrophils remained constant throughout the
experimental period in wild-type mice, whereas marrow neutro-
phil counts in mutant mice gradually declined to less than one
third of basal values at 48 h (Figure 6C). Moreover, blood
neutrophils recovered from wild type mice 24 h after cytokine
injection displayed enhanced survival, while neutrophils from
STAT5
2/2 mice did not (Figure 6D; compare with Figure 2A).
Therefore, when injected with pro-inflammatory cytokines,
mutant mice cannot increase neutrophil production and survival,
and are therefore unable to maintain neutrophil homeostasis.
Stromal cell-specific loss of STAT5 induces marked
neutrophilia
Based on the data presented above, we postulated that extinction
of STAT5 expression in LECs but not in cells of the granulocytic
lineage would induce prominent neutrophilia. To test the validity
of our hypothesis, we generated chimeric mice by adoptive bone
marrow transplantation after total body irradiation. Bone marrow
cells from control wild-type mice were transferred into lethally
irradiated STAT5
2/2 recipients (WTRKO) and vice versa
(KORWT). WTRWT and KORKO mice were used as
controls. Both KORKO and WTRKO mice displayed elevated
G-CSF serum levels, most likely due to the fact that their LECs
were capable of producing large amounts of this cytokine
(Figures 7A and 7B). The phenotype of WTRWT and KORKO
mice recapitulated that of primary wild-type and mutant mice,
respectively (Figures 7C–I; compare with Figure 2). In KORWT
mice, total numbers of HSCs, CMPs, GMPs, and bone marrow
and peripheral blood neutrophils were substantially reduced
relative to those in WTRWT and KORKO mice (Figures 7C
and 7E–H). Interestingly, however, apoptosis of HSCs, CMPs,
GMPs, and marrow and blood neutrophils was only slightly
increased in KORWT mice as compared with KORKO
counterparts in which G-CSF concentrations are much higher
(Figures 7D and 7I). As expected, WTRKO mice displayed
a significant increase in blood neutrophil counts when compared
with WTRWT mice (Figure 7C). Of note, the WTRKO mice
had blood lymphocytes in numbers similar to those in WTRWT
mice (data not shown). The pronounced neutrophilia found in
WTRKO mice was associated with substantial enhancement of
blood neutrophil survival (Figures 7D). Moreover, a significant rise
in total numbers and survival of bone marrow neutrophils, GMPs,
CMPs and HSCs was noted in KORWT mice compared to
WTRWT controls (Figures 7E–I). These results demonstrate that
loss of STAT5 expression in stromal cells, and especially in LECs,
is sufficient to induced marked neutrophilia.
DISCUSSION
Differentiation of blood cells from HSCs is controlled by lineage-
restricted transcription factors [30]. Several lines of evidence
suggest that STAT5 is an essential component of G-CSF-driven
cell proliferation and granulopoiesis [23,24,26,27]. Surprisingly,
however, STAT5
2/2 mice develop mild neutrophilia rather that
neutropenia [23,27]. In the present study, we provide an
r
Figure 5. Degradation of cytoplasmic STAT5b in WT LECs following inflammatory stimulation, and subsequent enhancement of G-CSF
production. (A) Wild-type mice were injected intravenously with PBS or with 2 mg recombinant murine TNF-a and 2 mg recombinant murine IL-1b.
Livers were harvested 30 min later, and liver sections were analyzed for STAT5b expression and localization by immunofluorescence and confocal
microscopy as described in the Experimental Procedures. (a) STAT5b was present in the cytoplasm (green), but not the nucleus (arrows), of LECs of
PBS-treated mice. (d) STAT5b was no longer detectable in LECs of cytokine-treated mice. All cell nuclei in the fields are shown by hexidium iodide
staining (red, b and e), and merges of frames (a) and (b), and (d) and (e), are given in (c) and (f), respectively. Bars=10 mm. (B) Livers collected from
cytokine-treated mice were assayed for G-CSF mRNA expression by quantitative RT-PCR. Livers were harvested before cytokine injection (T0), or either
1 (T1) or 4 (T4) hr postinjection. All values are normalized to b-actin mRNA. (C) Liver sections from untreated mice (left panel) and mice treated for
4 hr with TNF-a and IL-1b (right panel) were stained to visualize G-CSF (brown). Original magnification, 2506. (D) LSECs were isolated from wild-type
mice and cultured for 3 days before experiments were performed. Cells were treated for 0 (T0), 1 (T1), 3 (T3) or 6 (T6) hr with 100 IU/ml TNF-a and
500 pg/ml IL-1b. Cytoplasmic and nuclear extracts were prepared and analyzed for STAT5b expression by immunoblot. Equal loading of proteins on
the gel was confirmed by probing the blots for b-actin (cytoplasmic extracts) or Oct-1 (nuclear extracts). (E) Nuclear protein extracts were assessed for
STAT5 DNA-binding activity by EMSAs. Binding of Oct-1 was used as an internal standard. Nuclear extracts from prolactin-stimulated bovine MAC-T
cells were used as positive controls for STAT5 activation (control). (F) G-CSF concentrations in LSEC supernatants were measured by ELISAs. *,
significantly different from T0 values with P,0.05. (G) LSECs were isolated from wild-type mice and cultured for 3 days before experiments were
conducted. Cells were treated with 20 mM MG132 for 30 min prior to stimulation with 100 IU/ml TNF-a and 500 pg/ml IL-1b. Cytoplasmic extracts
were prepared 0 (T0), 1 (T1), 3 (T3), and 6 (T6) hr later and analyzed for STAT5b expression by immunoblot. Equal loading of proteins on the gel was
confirmed by probing the blots for b-actin. (H) LSECs stimulated for 0 (T0), 1 (T1), 3 (T3), and 6 (T6) hr with 100 IU/ml TNF-a and 500 pg/ml IL-1b were
assayed for STAT5b mRNA expression by real-time quantitative RT-PCR. All values were normalized to b-actin mRNA.
doi:10.1371/journal.pone.0000727.g005
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STAT5
2/2 mice, LECs autonomously produce high amounts of
G-CSF, allowing bone marrow progenitors to overcompensate for
their hyporesponsiveness to this cytokine.
STAT5 Functions in the Granulocytic Lineage
Apoptosis of HSCs, CMPs, GMPs, and bone marrow neutrophils
was increased in STAT5
2/2 mice, an observation consistent with
previous reports that survival of lin
dimSca-1
+ and lin
dimSca-1
neg/lo
bone marrow cells is decreased in the absence of STAT5 [26], and
that STAT5 may promote the survival of myeloid progenitors
through its ability to induce transcription of the bcl-x gene [25].
However, the HSC population was unchanged, and the CMP,
GMP, and bone marrow neutrophil populations were increased in
mutant mice compared with wild-type controls. To determine the
contribution of elevated G-CSF production by STAT5
2/2 LECs
to this phenotype, we have generated KORWT mice. In
KORWT mice, HSC, CMP, GMP, and bone marrow neutrophil
apoptosis was only slightly augmented relative to that in KORKO
control mice, whereas total HSC, CMP, GMP, and bone marrow
neutrophil counts were dramatically reduced. These results are
consistent with a model in which increased G-CSF production by
LECs in STAT5
2/2 mice triggers STAT5-independent compen-
satory mechanisms in various progenitors. These mechanisms
mask the intrinsic defect in STAT5
2/2 progenitor survival and
direct the commitment of progenitors to the granulocytic lineage.
The main action of G-CSF is not through induction of competing
antiapoptotic programs. Indeed, only moderate increase in
progenitor apoptosis was observed in the absence of elevated
G-CSF concentrations (viz. in KORWT mice). It is thus probable
that G-CSF exerts its effects by enhancing progenitor proliferation.
This hypothesis is supported by two independent observations.
First, both the lin
dimSca-1
+ and the lin
dimSca-1
neg/lo subsets
exhibit a 2-fold increase in the percentage of cells with DNA
content more than 2n in STAT5
2/2 mice [26]. Second,
STAT5
2/2 bone marrow cells stimulated in vitro with G-CSF
Figure 6. STAT5
2/2 mice are unable to maintain neutrophil homeostasis during cytokine-induced inflammation. (A) Wild-type (WT) and mutant
mice were injected intravenously with 2 mg recombinant murine TNF-a and 2 mg recombinant murine IL-1b. Serum G-CSF concentrations were
measured by ELISA before (T0) and 6 (T6), 24 (T24), and 48 (T48) hr after cytokine injection. (B) Blood neutrophils were counted at the different time
points. (C) Mature marrow neutrophils (CD11c
+Gr-1
hi cells) from control and mutant mice were counted by flow cytometry. Absolute values were
generated by multiplying gated percentages by total cell numbers. (D) Blood neutrophils were isolated by MACS from wild-type and mutant mice
24 hr after cytokine injection. Freshly purified (T0) and 24-hr cultured (T24) neutrophils were assayed for apoptosis using dual color annexin-V-FITC/
propidium iodide staining and flow cytometry analyses. (A–D) *, significantly different from WT values with P,0.05. u, significantly different from T0
values with P,0.05.
doi:10.1371/journal.pone.0000727.g006
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6 wild-type bone marrow cells were injected intravenously
into lethally irradiated (1,000 rad) STAT5
2/2 mice (WTRKO) and vice versa (KORWT). 8 weeks later, serum G-CSF concentrations were measured by
ELISA. Lethally irradiated wild-type mice reconstituted with wild-type bone marrow (WTRWT) and mutant mice reconstituted with mutant marrow
(KORKO) served as controls. (B) Liver sections were stained to detect G-CSF (brown). Original magnification, 2506. (C) Blood neutrophils were
counted. (D) Freshly MACS-purified (T0) and 24-hr cultured (T24) blood neutrophils were assayed for apoptosis using dual color annexin-V-FITC/
propidium iodide staining and flow cytometry analyses. (E–H) Mature marrow neutrophils, GMPs, CMPs, and HSCs were counted by flow cytometry.
Absolute values were generated by multiplying gated percentages by total cell numbers. (I) Freshly FACS-purified marrow neutrophils, GMPs, CMPs,
and HSCs were assayed for apoptosis using trypan blue exclusion.
doi:10.1371/journal.pone.0000727.g007
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STAT5
2/2 mice (500 pg/ml) displayed a 1.7-fold and a 2.5-fold
increase in proliferation, respectively, compared with wild-type
cells and mutant cells stimulated with G-CSF at a physiological
concentration (20 pg/ml) (Figure 3B). Further experiments are
required to determine whether G-CSF is the sole factor
responsible for the neutrophilia in STAT5
2/2 mice.
Neutrophil homeostasis was not maintained in STAT5
2/2 mice
following intravenous injection of TNF-a and IL-1b. Indeed,
although a rise in blood neutrophil counts was observed at 6h
postinjection, neutrophil numbers dropped significantly after 24
and 48 h. Maintenance of the neutrophil pool size during the
inflammatory response requires enhanced neutrophil production
[6]. G-CSF is the primary regulator of emergency granulopoiesis
[9–11]. Serum G-CSF levels increased from ,500 to 7,000 pg/ml
in STAT5
2/2 mice injected with pro-inflammatory cytokines.
However, the total number of bone marrow CD11b
+Gr-1
hi cells
declined concurrently to less than one third of basal values,
indicating that neutrophil release from bone marrow cannot be
compensated by efficient emergency granulopoiesis in these mice.
It is possible that the survival defect in STAT5
2/2 bone marrow
progenitors prevented the enhancement of neutrophil production
that is normally induced by increasing G-CSF concentrations.
This hypothesis is supported by our finding that proliferation of
STAT5
2/2 bone marrow cells plateaued at approximately
500 pg/ml G-CSF, which is the concentration measured in the
serum of STAT5
2/2 mice at steady state (Figure 3B). In wild-type
mice, inflammatory stimulation induced G-CSF production by
LECs and other cell types (principally macrophages), and thus
sustained neutrophil mobilization and expansion. We conclude
that STAT5-mediated antiapoptosis in myeloid progenitors is
required for efficient emergency granulopoiesis.
Blood neutrophils from STAT5
2/2 mice were fully differenti-
ated. Moreover, STAT5
2/2 neutrophils displayed a respiratory
oxidative burst, increased expression of surface markers following
stimulation, and the ability to migrate, to produce high quantities
of TNF-a, and to phagocytose and kill bacteria. STAT5 is
therefore dispensable for neutrophil differentiation and function.
Of all the cells of the immune system, the neutrophil has the
shortest half-life, estimated to be between 6 and 18 h. This short
half-life arises from the fact that bloodstream neutrophils rapidly
undergo spontaneous apoptosis [1]. The apoptosis rate was slightly
but significantly greater in peripheral blood neutrophils from
STAT5
2/2 mice than in those from wild-type littermates,
indicating that at steady state, STAT5 contributes to homeostatic
regulation of peripheral blood neutrophil numbers by inducing
antiapoptotic mechanisms not only in progenitors but also in
circulating neutrophils.
Delayed neutrophil apoptosis has been associated with several
infectious and inflammatory diseases [31]. This enhancement of
neutrophil survival presumably allows them to function more
effectively at sites of inflammation. The suppression of neutrophil
apoptosis in vivo is mainly due to overexpression of survival
factors, two most important of which are G-CSF and GM-CSF
[5,32]. In our study, STAT5
2/2 neutrophils, unlike wild-type
neutrophils, were refractory to G-CSF and GM-CSF-induced
antiapoptosis in vitro. Moreover, survival of circulating neutrophils
was not enhanced in STAT5
2/2 mice following inflammatory
stimulation, indicating that STAT5 is a critical mediator of
delayed neutrophil apoptosis in vivo. In chronic inflammatory
diseases, accumulation of long-lived neutrophils at the site of
inflammation is deleterious rather than beneficial. We postulate
that selective inhibition of STAT5 could have therapeutic value in
the control of these disorders.
Functions of STAT5b in LSECs
The most striking finding of our work is that LECs and, to
a lesser extent, auricle and aorta endothelial cells of STAT5
2/2
mice autonomously secrete G-CSF. This situation is recapitu-
lated in wild-type mice upon inflammatory stimulation. Indeed,
rapid degradation of STAT5b, which is the sole STAT5 isoform
present in LECs, precedes G-CSF expression and secretion by
LECs in wild-type mice injected with TNF-a and IL-1b.T o
examine direct effects of inflammatory stimulation on STAT5b
protein expression, isolated wild-type LSECs were treated ex
vivo with TNF-a and IL-1b. Again, STAT5b was rapidly
degraded following pro-inflammatory cytokine stimulation.
Taken together, these data show that STAT5b negatively
regulates granulopoiesis at steady-state by directly or indirectly
repressing G-CSF expression in liver endothelium, and that
cytokine-induced removal of this STAT5b-imposed brake
triggers G-CSF production and secretion. To address the
question of whether enhancement of G-CSF production that
results from STAT5b degradation in LECs may contribute to
induction of emergency granulopoiesis, we have generated
WTRKO mice. In these mice, bone marrow-derived cells
were normal, whereas LECs were deficient for STAT5 and thus
produced large amounts of G-CSF. Total numbers and survival
of CMPs, GMPs, and bone marrow and peripheral blood
neutrophils were significantly increased in WTRKO mice
relative to WTRWT control mice, demonstrating that loss of
STAT5 expression in LECs is sufficient to provoke emergency
granulopoiesis and eventually neutrophilia. We conclude that in
LECs, STAT5b is a stress sensor, the degradation of which
allows conversion of systemic inflammatory signals into signals
that promote granulopoiesis. Of note, although chimeric
WTRKO mice had normal numbers of blood lymphocytes,
they developed neutrophilia and their LECs produced high
amounts of G-CSF, indicating that increased G-CSF production
and granulopoiesis in STAT5
2/2 mice does not reflect
a compensatory mechanism for a decreased absolute lymphocyte
count.
In the present study, we have demonstrated that G-CSF
expression in LECs is repressed by cytoplasmic rather than by
nuclear STAT5b. It is known that STAT5 can function to not only
stimulate but also inhibit gene transcription [33], and a number of
mechanisms have been described by which STAT5 acts as
a repressor [34,35]. For example, consistent with our observations,
the STAT5b VVVI mutant, which remains primarily cytoplasmic
and does not accumulate significantly in the nucleus even after
prolactin stimulation, is capable of inhibiting STAT1-mediated
activation of the interferon regulatory factor-1 promoter at an
extranuclear level [35]. An intriguing question is how cytoplasmic
STAT5b can repress G-CSF expression in LECs. Regulation of G-
CSF gene expression is achieved at the level of transcription as
well as post-transcriptionally [15]. Thus, a possible mechanism
may be that STAT5b competes for a cytoplasmic factor required
for G-CSF gene transcription in the nucleus. Alternatively,
cytoplasmic STAT5b may interfere with RNA-binding proteins
or RNAse activity, thereby increasing G-CSF transcript instability.
Further studies are needed to address these questions. Enhance-
ment of G-CSF mRNA and protein expression in pro-inflamma-
tory cytokine-stimulated LECs follows rapid degradation of
cytoplasmic STAT5b. It has been reported that the adapter
molecule c-Cbl negatively regulates STAT5-mediated transcrip-
tion by inducing ubiquitination and proteosomal degradation of
cytoplasmic STAT5 [29]. Similarly, our results show that in LECs,
pro-inflammatory cytokines activate intracellular pathways leading
to proteosomal degradation of STAT5b.
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Mice
All animal protocols were approved by the Animal Ethics
Committee of the University of Lie `ge. STAT5
2/2 mice were
obtained from Dr James Ihle (St Jude Children’s Research
Hospital, Memphis, TN) and backcrossed 8 generations onto the
C57Bl/6 background. Heterozygote mice were then crossed to
yield homozygous double-knockout mice for analysis. All studies
were performed on 6- to 10-week mice, and littermates were
always used as wild-type controls. Mice were genotyped by PCR of
tail DNA as previously described [23]. The primers consisted of
STAT5a: F9 primer (59-AAGGGACAGGAAGAGAGAAGG-39),
R1 primer (59-CCCATACAACACTTGCATCT-39); herpes
simplex virus thymidine kinase (TK) cassette: TKp primer (59-
GCAAAACCACACTGCTCGAC-39); STAT5b: R8 primer (59-
GGAGATCTGCTGGCTGAAAG-39), F11 primer (59-TCAAA-
CACACCTCAATTAGTC-39). A representative PCR performed
on tail DNA from STAT5
+/+, STAT5
+/2, and STAT5
2/2 mice is
provided in Figure 8A.
As previously described in the 129/SvJ background [23],
approximately one-third of the double-knockout C57Bl/6 mice
died within 48 hr. Moreover, the STAT5a/b-deficient C57Bl/6
mice were smaller than wt counterparts (the STAT5
2/2 mice
weighed ,30% less than the wt littermates), and the females were
infertile, as previously reported by Teglund et al. [23].
It has been demonstrated that N-terminally truncated STAT5a
and STAT5b proteins (STAT5aDN and STAT5bDN) may be
produced in several cell types of STAT5
2/2 mice [36]. These
proteins lack approximately 100 amino acids, but are likely to
display some transcriptional activity. Immunoblots were per-
formed in order to ensure that the STAT5DN proteins were only
expressed at low levels in STAT5
2/2 neutrophils and LSECs, and
therefore to ascertain that our observations in deficient mice were
not the result of some aberrant function of the truncated STAT5
proteins. Our experiments showed that the STAT5DN proteins
were barely detectable in STAT5
2/2 neutrophils and LSECs
(Figures 8B and 8C). STAT5aDN and STAT5bDN only occurred
at 5% or less of the normal levels, as determined by densitometry.
Peripheral Blood Counts
Complete blood counts were determined using a Coulter counter.
Differentials counts were performed on blood smears stained with
Wright-Giemsa.
Thioglycollate-Induced Peritonitis
Mice were injected intraperitoneally with 2 ml of 3% TGA broth
(DIFCO). Peritoneal exudate cells were harvested after 4 h by PBS
lavage. Red blood cells were lysed in Tris-buffered ammonium
chloride (pH 7.2) buffer, and leukocytes were enumerated using
a Coulter counter. Leukocyte differentials performed on cytospins
Figure 8. Characterization of wild-type and STAT5
2/2 C57Bl/6 mice. (A) Tail DNA from STAT5
+/+, STAT5
+/2, and STAT5
2/2 C57Bl/6 mice was
prepared and PCR were performed to amplify wild-type stat5a and stat5b DNA as well as the TK cassette. The primers are given in the Material and
methods section. (B) LSECs were isolated from wild-type (WT) and STAT5
2/2 mice. Whole-cell extracts were prepared and analyzed for STAT5b and
STAT5bDN expression by immunoblot. We used an antibody (G-2) directed to an epitope mapping at the C-terminus of STAT5b. Equal loading of
proteins on the gel was confirmed by probing the blots for b-actin. (C) Blood neutrophils were isolated from WT and STAT5
2/2 mice. Whole-cell
extracts were prepared and analyzed for STAT5b/STAT5bDN (left panel) and STAT5a/STAT5aDN (right panel) expression by immunoblot. For STAT5b/
STAT5bDN, we used the G-2 antibody. For STAT5a/STAT5aDN, we used an antibody (L-20) raised against a peptide mapping at the C-terminus of
STAT5a. Equal loading of proteins on the gel was confirmed by probing the blots for b-actin.
doi:10.1371/journal.pone.0000727.g008
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exudate cells were neutrophils. Peritoneal cells were also stained
with anti-CD11b-FITC and anti-Gr-1-PE antibodies (BD Phar-
mingen), and analyzed by FACS.
Respiratory Burst Assay
Dihydrorhodamine 123 oxidation assay was performed as de-
scribed [37]. In brief, 1610
6 peritoneal neutrophils harvested by
lavage from TGA-treated mice were incubated with 100 mM
dihydrorhodamine and 1000 U/ml catalase in 100 mL of medium
at 37uC for 5 min. One hundred microliters of medium containing
200 ng PMA was added and incubated for another 20 min. Cells
were washed with cold PBS twice, resuspended in PBS containing
1% paraformaldehyde, and analyzed by FACS.
Phagocytosis and Bactericidal Assays
Phagocytosis and bactericidal assays were performed as described
[21] with some modifications. In brief, peritoneal neutrophils from
TGA-treated mice were washed and resuspended in medium
lacking antibiotics. 10
7 live Staphylococcus aureus labeled with 5 mM
CFSE was mixed with 2610
6 neutrophils and incubated at 37uC
for 30 min. Subsequently, extracellular bacteria were killed by
incubation for an additional 30 min with 50 mg/ml gentamycin.
Phagocytic activity was assessed by FACS. To measure bacteri-
cidal activity, engulfed bacteria were released by lysing neutrophils
in 1 ml water. One hundred microliters of a 1:1,000 dilution of the
bacterial suspension was plated and colonies were counted after
a 24 h incubation at 37uC.
Bone Marrow Cytology
Bone marrow cells were collected from both hind limbs (tibias and
femurs), counted using a Coulter counter, prepared by cytospin
centrifugation, and stained with Wright-Giemsa. Differential cell
counts were scored visually on coded slides. Mature marrow
neutrophils were counted based on CD11b and Gr-1 expression
(CD11b
+Gr-1
hi cells). The bone marrow precursor populations
were counted on the basis of the expression of specific membrane
markers [38]. The CMP population was identified as Lin
2Sca-
1
2IL-7Ra
2c-kit
+CD34
+FccR
low cells. GMPs were defined as
Lin
2Sca-1
2IL-7Ra
2c-kit
+CD34
+FccR
+ cells. HSCs were defined
as Lin
2Sca-1
hiIL-7Ra
2c-kit
hi.
Isolation of Mature Neutrophils and Bone Marrow
Progenitors
Blood was collected into heparinized tubes. Red blood cells were
removed by lysis in hypotonic buffer. Cells were then washed twice
in PBS, stained with biotin-conjugated anti-Gr-1 antibody (BD
Pharmingen), and selected with streptavidin-coated magnetic
beads (Miltenyi Biotech). Marrow neutrophils were FACS-sorted
based on CD11b and Gr-1 expression (CD11b
+Gr-1
hi cells). Purity
of isolated cells, as determined by counting of cytospin prepara-
tions stained with Wright-Giemsa, was always .90%. HSCs,
CMPs, and GMPs were FACS-sorted based on the expression of
specific membrane markers (see above). Neutrophils were cultured
at 37uC in RPMI 1640 medium supplemented with 1% glutamine,
10% FCS, 50 mg/ml streptomycin, and 50 IU/ml penicillin.
Apoptosis Assays
Neutrophils were assayed for apoptosis using dual color annexin-
V-FITC/propidium iodide staining (Roche) and flow cytometry
analyses. Freshly isolated progenitors were assayed for apoptosis
using trypan blue exclusion. For antiapoptosis assays, neutrophils
were cultured for 24 h in the presence of 0.5 or 25 ng/ml G-CSF
or 25 ng/ml GM-CSF.
Proliferation Assays
Bonemarrowcellswereseededat2610
5cells per well and incubated
for 48 h at 37uC in the presence of increasing concentrations of
recombinant murine G-CSF. Cells were then pulsed with 1 mCi
3[H]thymidine and incubated for a further 16 h prior to harvest.
Real Time Quantitative RT-PCR
Total RNA from various organs and tissues or from stimulated
LSECs was extracted using Trizol (Invitrogen) and reverse
transcribed with the AMV reverse transcriptase (Roche). Ampli-
fication reactions were performed using SybrGreen reaction mix
(Eurogentec) in the presence of 0.5 ml of total cDNA and 300 nM
of specific primers for either murine G-CSF (TGCTTAAGT-
CCCTGGAGCAA and AGCTTGTAGGTGGCACACAA) or
murine STAT5b (CAGGTGGTCCCCGAGTTTGCA and CA-
GATCGAAGTCCCCATCGGTA). Real time PCR and fluores-
cence quantification were performed in a Lightcycler GenAmp
5700 (Applied Biosystems). The level of b-actin mRNA was used
as an internal control for normalization.
Immunohistochemistry
Immunohistochemical techniques used in this study were de-
scribed in detail by Pajak et al [39]. Organs were fixed for 3 days
in Immunohistofix (A PHASE) followed by dehydration in
a graded series of ethanol (30, 50, 70, 90, and 100%) for 30 min
each at room temperature. Tissues were embedded in Immuno-
histowax (A PHASE), sectioned at 3 to 6 mm, de-embedded by
washing in acetone for 5 min, and transferred to PBS. The
endogenous peroxidase activity was neutralized by 3% H2O2 in
PBS for 60 min. Tissue sections were treated for 30 min with 1%
blocking reagent (BR; Boehringer), and the slides were incubated
with 10 mg/ml anti-G-CSF rabbit polyclonal antibody (FL-207,
Santa Cruz Biotechnology). Slides were then incubated with
20 mg/ml protein A-HRP (Sigma) and stained with a solution of
3-amino-9-ethylcarbazole (Sigma). Sections were counterstained
with Mayer’s hemalum (Merck). No staining was observed when
the primary antibody was omitted.
Immunofluorescence Confocal Microscopy
Livers were frozen in isopentane and 10 mm cryostat sections were
prepared. Sections were air dried and saturated in PBS plus 1%
BR mixed with equal volume of culture supernatant containing
anti-mouse CD16/CD32 monoclonal antibodies (2.4G2). Slides
were washed in PBS, and incubated for 1 h at room temperature
with 25 mg/ml anti-STAT5b mouse monoclonal antibody (G-2;
Santa Cruz Bitoechnology) in PBS-BR-2.4G2. The slides where
then washed three times with PBS-BR and incubated for 1 h with
a 1:200 dilution of Alexa-488-coupled goat anti-mouse IgG
(Molecular Probe) and with 20 mM hexidium iodide (Molecular
Probe) for nuclear staining. The samples were then washed three
times in PBS containing 0.2% gelatine and mounted for analysis
on a Zeiss LSM510 laser scanning confocal microscope. No
staining was observed when the primary antibody was omitted. No
signal was observed when the slides were stained using an anti-
STAT5a antibody (L-20; Santa Cruz Biotechnology).
Isolation of Liver Sinusoidal Endothelial Cells
LSECs were isolated as previously described [40], seeded onto 6-
well flat-bottom plates (Becton Dickinson) at a density of 5610
6
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performed. In some experiments, LSECs were stimulated with
100 IU/ml recombinant murine TNF-a and 500 pg/ml recombi-
nant murine IL-1b (Peprotech).
Inflammatory Stimulation
To induce inflammation, mice were injected intravenously with
2 mg recombinant murine TNF-a and 2 mg recombinant murine
IL-1b (Peprotech).
Immunoblots
Cytoplasmic, nuclear and whole-cell extracts as well as immuno-
blots were performed as previously described [41]. Various anti-
STAT5a and/or anti-STAT5b antibodies were used (G-2, L-20,
N-20, C-17; Santa Cruz Biotechnology). An anti-STAT5b
antibody (G-2) was used in Figures 5D, 5G, 8B, and 8C. STAT5b
G-2 is a mouse monoclonal antibody epitope mapping at the C-
terminus of STAT5b of mouse origin. An anti-STAT5a antibody
(L-20) was used in Figure 8C. STAT5a L-20 is an affinity purified
rabbit polyclonal antibody raised against a peptide mapping at the
C-terminus of STAT5a of mouse origin. Equal loading of proteins
on the gel was confirmed by probing the blots for b-actin or Oct-1.
In experiments aimed at determining whether STAT5b was
degraded by the proteasome, LSECs were treated with 20 mM
MG132 (AG Scientific Inc.).
Electrophoretic Mobility Shift Assays
Electrophoretic mobility shift assays and supershift experiments
were performed as described elsewhere [39]. The sequence of the
STAT5 probe (viz. the 21 bp GAS-like element from the promoter
of the bovine b-casein) used in this work was as follows: 59-
AGATTTCTAGGAATTCAAATC-39. To confirm specificity,
competition assays were performed with a 50-fold excess of
unlabeled wild-type probes and with mutated probes (data not
shown). Binding of the non inducible transcription factor Oct-1
was used as an internal standard. In some experiments, nuclear
extracts from MAC-T cells (bovine mammary epithelial cells;
NEXIA Biotechnologies Inc.) stimulated with purified bovine
prolactin were used as positive controls for STAT5 activation.
Cytokine Assays
G-CSF, GM-CSF, IL-3, SCF, and TNF-a protein levels in serum
and/or in culture supernatants were determined by ELISA (R&D
or Endogen).
Bone Marrow Transplantation
5610
6 wild-type or STAT5
2/2 bone marrow cells were injected
intravenously into lethally irradiated (1000 rad) control or mutant
mice (8-week-old mice were used). Eight weeks later, blood, bone
marrow and liver samples were prepared for Wright-Giemsa
staining, FACS analysis, cytokine assays, or immunohistochemis-
try. There were 6 mice in each experimental group (WTRWT,
WTRKO, KORKO, and KORWT). The experiments were
repeated 3 times.
Statistical Analysis
Data are presented as means6SDs. The differences between mean
values were estimated using either an ANOVA with subsequent
Fisher’s protected least significant difference tests or a Student’s t
test for unpaired data. A value of P,0.05 was considered
significant. All the experiments were repeated at least three times.
n $ 6 in each experimental group.
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